Clinical trials
Liver Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2006 | 5 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Active, not recruiting | 9 |
| Recruiting | 9 |
| Terminated | 6 |
| Unknown status | 5 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 8 |
| Asan Medical Center | 6 |
| AstraZeneca | 5 |
| Bristol-Myers Squibb | 5 |
| Jennerex Biotherapeutics | 5 |
| Bayer | 4 |
| Novartis Pharmaceuticals | 3 |
| Coherus Oncology, Inc. | 2 |
| Ethicon, Inc. | 2 |
| Imunon | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 76 |
| Carcinoma, Hepatocellular | 46 |
| Neoplasms | 11 |
| Liver Diseases | 5 |
| Neoplasm Metastasis | 5 |
| Carcinoma | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Stomach Neoplasms | 4 |
| Biliary Tract Neoplasms | 3 |
| Cholangiocarcinoma | 3 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.